Pharmafile Logo

Poisson Rouge

Poisson Rouge is a London based company that specialises in producing unique and high impact teambuilding activities, people development programmes and event management services. For nearly 20 years we have been combining our passion and creativity to create some of the most unusual, fun, and exciting team events and some of the most innovative ways to develop people available anywhere on Earth. However, instead of wanging on about how great we think we are we thought we’d just let our unique ideas, our long track record of success and our clients do the talking!

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Amiculum

AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…

View Profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.

View Profile

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Company Details

96 west yard, Camden Lock Place, London, N6 6BL, United Kingdom
+44 (0)20 7267 3646

 Latest Content from PMHub 

Improving healthcare for rare disease patients

Following on from Rare Disease Day 2022, we decided to take a deeper look into the patient journey of those living with a rare health condition. In this blog, we...

Gamifying Remote Patient Monitoring

Dr. Emilia Molimpakis, CEO & Co-founder of Thymia, shares how their platform uses video games based on neuropsychology, alongside analyses of facial microexpressions and speech, to quickly, accurately, and objectively...

Fishawack Health expands its value, evidence, and market access capabilities with the acquisition of HEOR consultancy Policy Analysis Inc. (PAI)

Press Releases | March 3, 2022 | Avalere Health

Fishawack Health announces its expanded global Value, Evidence, and Access (VEA) capability for biopharmaceutical and medical technology companies, with a suite of end-to-end services spanning product lifecycle, coupled with unsurpassed...

Onyx Health Announces a “Double Hatrick” of New Appointments

Press Releases | March 3, 2022 | Onyx Health

Onyx Health continues to expand with six new appointments to its creative and communication teams, due to increased growth in its international client portfolio work.

Utilising Patient Insight in Pharma Marketing

The importance in understanding the patients view point when marketing in Pharma (Article written August 30th 2021)

Office move signals new era for Berkshire agency

Dice Medical Communications moves office due to business growth

How a Copywriter Reads a Clinical Paper

What key elements you need to consider in a clinical paper (Article written November 18th 2021)

What does HCP engagement look like in a post-Covid world?

HCP engagement has changed as a result of the Covid-19 pandemic, with pharmaceutical companies and agencies having to rapidly adjust to a new way of communicating. Digital channels have become...

Placing people at Lucid’s heart: Paul Cutler, Lucid Group’s new Chief People Officer

We interviewed Paul Cutler, Lucid Group’s new Chief People Officer, to find out a bit more about what makes him tick, why he chose to join Lucid, and what his...